Hunter Reese

Scientist II at Asklepios Biopharmaceutical

Speaker

Hunter Reese is a downstream process development scientist at Asklepios Biopharmaceutical, a gene therapy company. He has experience with AskBio’s platform development method, DoE development strategies, and gene therapy scale up activities. He has worked with several different recombinant adeno-associated virus serotypes and target indications. He previously worked at KBI Biopharma on a variety of protein therapeutics, and he earned his PhD at NC State University on work developing and characterizing affinity resins for Fc-containing products.